Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design

By Madan Ravi A   Mohebtash Mahsa   Schlom Jeffrey   Gulley James L  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 1, 2010-01 ,pp. : 19-28

Informa Healthcare

Access to resources Recommend Favorite

Denosumab for treatment of breast cancer bone metastases and beyond

By Nangia Julie R   Ma Joseph D   Nguyen Christine M   Mendes Margaret AS   Trivedi Meghana V  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 4, 2012-04 ,pp. : 491-501

Informa Healthcare

Access to resources Recommend Favorite

In vitro assessment of intestinal permeability and hepatic metabolism of 4′-bromoflavone, a promising cancer chemopreventive agent

By Li Y.   Grubjesic S.   Nikolic D.   Zhu D.   Kosmeder J. W.   Moriarty R. M.   Pezzuto J. M.   Van Breemen R. B.  

Xenobiotica, Vol. 34, Iss. 6, 2004-06 ,pp. : 535-547

Informa Healthcare

Access to resources Recommend Favorite

A glycolipid containing a lactose residue: A novel agent for targeted DNA delivery for the purpose of genetic therapy

By Bogdanenko E.   Zhdanov R.   Sebyakin Yu.   Zarubina T.   Vlasov V.  

Doklady Biochemistry & Biophysics, Vol. 401, Iss. 1-6, 2005-03 ,pp. : 145-149

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

L-BLP25: a MUC1-targeted peptide vaccine therapy in prostate cancer

By Sangha Randeep   North Scott  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 11, 2007-11 ,pp. : 1723-1730

Informa Healthcare

Access to resources Recommend Favorite